Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat-Reference-Cited by-同舟云学术

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

Published:2023-01 Issue:1 Volume:21 Page:143-152.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Lawitz Eric J.,Bhandari Bal Raj,Ruane Peter J.,Kohli Anita,Harting Eliza,Ding Dora,Chuang Jen-Chieh,Huss Ryan S.,Chung Chuhan,Myers Robert P.,Loomba Rohit

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation;Goldberg;Gastroenterology,2017

3. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease;Donnelly;J Clin Invest,2005

4. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites;Neuschwander-Tetri;Hepatology,2010

5. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges;Dufour;Gut,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

2. Fenofibrate-promoted hepatomegaly and liver regeneration are PPARα-dependent and partially related to the YAP pathway;Acta Pharmaceutica Sinica B;2024-07

3. Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD;Metabolism;2024-06

4. MAFLD as part of systemic metabolic dysregulation;Hepatology International;2024-04-09

5. The Impact of Administration of Fenofibrate During Suckling on Glucose Homeostasis and Programming of Metabolic Function in Adolescent Sprague Dawley Rats;Biomedical and Pharmacology Journal;2024-03-20